These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 15077160
1. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T. Oncogene; 2004 Jun 17; 23(28):4921-9. PubMed ID: 15077160 [Abstract] [Full Text] [Related]
2. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018 [Abstract] [Full Text] [Related]
3. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Ni Z, Lou W, Leman ES, Gao AC. Cancer Res; 2000 Mar 01; 60(5):1225-8. PubMed ID: 10728680 [Abstract] [Full Text] [Related]
4. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines. Gu L, Chiang KY, Zhu N, Findley HW, Zhou M. Exp Hematol; 2007 Jun 01; 35(6):957-66. PubMed ID: 17533050 [Abstract] [Full Text] [Related]
5. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y, Chiba T. Oncogene; 2003 Jan 30; 22(4):548-54. PubMed ID: 12555068 [Abstract] [Full Text] [Related]
6. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Scheper MA, Nikitakis NG, Sauk JJ. Int J Oral Maxillofac Surg; 2007 Jul 30; 36(7):632-9. PubMed ID: 17566705 [Abstract] [Full Text] [Related]
7. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Paner GP, Silberman S, Hartman G, Micetich KC, Aranha GV, Alkan S. Anticancer Res; 2003 Jul 30; 23(3B):2253-60. PubMed ID: 12894500 [Abstract] [Full Text] [Related]
8. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Cancer Res; 2002 Nov 15; 62(22):6659-66. PubMed ID: 12438264 [Abstract] [Full Text] [Related]
9. Evaluation of potential Stat3-regulated genes in human breast cancer. Hsieh FC, Cheng G, Lin J. Biochem Biophys Res Commun; 2005 Sep 23; 335(2):292-9. PubMed ID: 16081048 [Abstract] [Full Text] [Related]
10. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Gong W, Wang L, Yao JC, Ajani JA, Wei D, Aldape KD, Xie K, Sawaya R, Huang S. Clin Cancer Res; 2005 Feb 15; 11(4):1386-93. PubMed ID: 15746037 [Abstract] [Full Text] [Related]
11. Bacterial N-acylhomoserine lactone-induced apoptosis in breast carcinoma cells correlated with down-modulation of STAT3. Li L, Hooi D, Chhabra SR, Pritchard D, Shaw PE. Oncogene; 2004 Jun 17; 23(28):4894-902. PubMed ID: 15064716 [Abstract] [Full Text] [Related]
12. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ. Oncogene; 2002 Dec 05; 21(55):8404-13. PubMed ID: 12466961 [Abstract] [Full Text] [Related]
13. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S. Clin Cancer Res; 2005 Nov 01; 11(21):7674-82. PubMed ID: 16278387 [Abstract] [Full Text] [Related]
14. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC. Prostate; 2004 Sep 01; 60(4):303-9. PubMed ID: 15264241 [Abstract] [Full Text] [Related]
15. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG. Cancer Res; 2008 May 01; 68(9):3152-60. PubMed ID: 18451140 [Abstract] [Full Text] [Related]
16. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Zhang YW, Wang LM, Jove R, Vande Woude GF. Oncogene; 2002 Jan 10; 21(2):217-26. PubMed ID: 11803465 [Abstract] [Full Text] [Related]
17. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E, Monti E. Cancer Lett; 2007 Dec 18; 258(2):181-8. PubMed ID: 17920763 [Abstract] [Full Text] [Related]
18. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA. Cancer Res; 2005 Jun 15; 65(12):5054-62. PubMed ID: 15958548 [Abstract] [Full Text] [Related]
19. Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells. Jiang H, Yu J, Guo H, Song H, Chen S. Biochem Biophys Res Commun; 2008 Mar 28; 368(1):1-5. PubMed ID: 18242580 [Abstract] [Full Text] [Related]
20. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Konnikova L, Simeone MC, Kruger MM, Kotecki M, Cochran BH. Cancer Res; 2005 Aug 01; 65(15):6516-20. PubMed ID: 16061629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]